Company profile
Ayr Wellness Inc.
OTC: AYRWF · Healthcare · Drug Manufacturers - Specialty & Generic
#218 of 1,418 Healthcare companies by revenue42nd-percentile growth
EA Score
——FH —DQ 6GM —SS 48
v0.1 · 25/100 weight · pillars only
↑ workforce scale, Piotroski F · ↓ filing timeliness, disclosure history
Methodology →Revenue TTM
$452.9M
Rev growth YoY (TTM)
-2.4%
Net income (FY)
-$359.3M
Employees
2,440
as of 2026-08-25
Market cap
$432.1k
as of 2026-08-25
Financials — latest annual
SEC EDGAR · USD-normalizedConceptUSDNativeFY
Revenue$463.6M$463.6M2024
Net income-$359.3M-$359.3M2024
Operating income-$161.0M-$161.0M2024
Total assets$1.3B$1.3B2024
Liabilities$904.3M$904.3M2024
Equity$379.5M$379.5M2024
Revenue trend
FY2023 – FY2024 · USD
FY23
FY23
FY24
Revenue by segment
No segmentation disclosed for this filer. n/a
The read
What is Ayr Wellness Inc.’s revenue?
Ayr Wellness Inc. booked $463.6M in FY2024 revenue, growing 0.0% year over year — about the middle of the pack among Healthcare companies we track, at a -77.5% net margin.
Peers · Healthcare
Inyx, Inc.——Travere Therapeutics, Inc.74BPhreesia, Inc.68BAccuray Incorporated68BTarsus Pharmaceuticals, Inc.62CArtivion, Inc.80B+Neighbors
Miami-Dade →Key facts
CEOScott Davido
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
HeadquartersMiami, FL
ExchangeOTC: AYRWF
Employees2,440
IPO date2020-12-04
Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.